Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Mark Smith CEO at Finch Therapeutics


Through his work at Finch and OpenBiome, Mark Smith hopes to unlock the potential of the microbiome to improve human health. With a background in computational microbiology, he is deeply interested in the complex interactions between humans and our hidden microbial majority. He is particularly keen to explore therapeutic applications for modulating these interactions to address important unmet medical needs.

Agenda Sessions